title: Targeting Myocardial Reperfusion Injury--The Search Continues.
authors: From the Hatter Cardiovascular Institute, University College London, and the National Institute of Health Research University College London Hospitals Biomedical Research Centre - both in London (D.J.H., D.M.Y.); and the Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, and the National Heart Research Institute Singapore, National Heart Center Singapore - both in Singapore, Singapore (D.J.H.).
authors: Derek J
authors: DJ
authors: Hausenloy
authors: Derek M
authors: DM
authors: Yellon
mesh_terms: D021983:Cyclophilins / Q000037:antagonists & inhibitors*; D016572:Cyclosporine / Q000008:administration & dosage*; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D062645:Percutaneous Coronary Intervention; D020257:Ventricular Remodeling / Q000187:drug effects*
chemical_list: D004791:Enzyme Inhibitors; D016572:Cyclosporine; D021983:Cyclophilins